Natco ruling is a watershed

The day of the nation-wide trade union strike, few people are on the roads and in offices in Mumbai. But on the second floor of the Patent Controller's office, a handful of people sit around a horse-shoe-shaped table, in a post-lunch session. They are listening to final arguments on pharmaceutical company Natco's application, seeking a compulsory licence on Bayer's Nexavar, an advanced kidney cancer medicine. It is also the last hearing of Mr P. H. Kurian, as Patent Controller General.

Read Full Story>>